| pubmed-article:2491421 | pubmed:abstractText | To review the rationale for using angiotensin converting enzyme (ACE) inhibitors in progressive renal disease, and to evaluate the experience with these agents in patients with hypertension and renal insufficiency. | lld:pubmed |
